![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif)
carcinoembryonic antigen peptide 1-6D A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). CEA:571-579 peptide, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif) | CEA:571-579 (576D) mCEA Peptide Modified CEA Peptide | | ![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif) | Abbreviations: | ![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif) | CAP-1-6D peptide CEA PEP 1-6D | | ![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090115055037im_/http://www.cancer.gov/images/spacer.gif) |